# Phathom Pharmaceuticals, Inc. – FDA 483, Jul 31, 2026

Source: https://www.keypedia.com/records/483/phathom-pharmaceuticals-inc/2da1c00d-69a3-4905-b2b8-c23e38d8f124

> FDA 483 for Phathom Pharmaceuticals, Inc. on July 31, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Phathom Pharmaceuticals, Inc.
- Inspection Date: 2026-07-31
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: An FDA inspection of Phathom Pharmaceuticals, Inc., a corporate headquarter in Buffalo Grove, IL, identified one observation related to postmarketing safety reporting. The firm failed to include copies of published scientific articles with expedited 15-day Alert reports submitted to the FDA. This indicates a deficiency in documentation practices for adverse event reporting.

## Related Officers

- [Ruth E. Medcalf](https://www.keypedia.com/people/ruth-e-medcalf/71a61d32-807b-4b73-9ea7-b59287e14e56)
- [investigator](https://www.keypedia.com/people/jeanne-j-thai/f7b057a4-ab4c-43de-a448-384ff9f8598f)

Company: https://www.keypedia.com/companies/phathom-pharmaceuticals-inc/e0db2f80-e368-49ac-839f-282cb240bb58

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669